Abstract
The issue number is given in front of the pagination
Aarsland, D., see Vallortigara, J. (1) 101–110
Aarsland, D., see Vijayaraghavan, S. (2) 567–576
Adjaye, J., see Wruck, W. (4) 1065–1082
Adluru, N., see Melah, K.E. (3) 873–886
Agamennoni, O., see Fernández, G. (3) 827–838
Agarwal, A.R., see Deochand, C. (2) 373–386
Agarwal, A.R., see Yu, R. (1) 133–148
Aharon-Peretz, J., see Malishkevich, A. (1) 249–260
Alcolea, D., see Carmona-Iragui, M. (1) 1–7
Alcolea, D., see Morenas-Rodríguez, E. (2) 539–546
Alegret, M., see Ibarria, M. (2) 559–566
Alemán-Gómez, Y., see Lacalle-Aurioles, M. (4) 1051–1064
Alexander, A.L., see Melah, K.E. (3) 873–886
Alexander, R.C., see Eketjäll, S. (4) 1109–1123
Alghamdi, A., see Vallortigara, J. (1) 101–110
Allali, G., see Wang, N. (3) 699–707
Andersen, B.B., see Hoffmann, K. (2) 443–453
Ando, Y., see Mishima, A. (1) 161–174
Andreassen, O.A., see Vijayaraghavan, S. (2) 567–576
Antenucci, M., see Siotto, M. (4) 1181–1189
Anthonissen, R., see Maes, A. (3) 741–749
Antoine, P., see Avondino, E. (1) 89–99
Antón-Aguirre, S., see Carmona-Iragui, M. (1) 1–7
Arai, H., see Yamashita, S. (2) 527–537
Arai, T., see Takahashi, S. (3) 751–758
Arcaro, M., see Oldoni, E. (2) 353–357
Ardekani, B.A., A. Convit and A.H. Bachman, Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression (3) 847–857
Aricò, M., see Gallucci, M. (4) 969–979
Arighi, A., see Oldoni, E. (2) 353–357
Arosio, B., see Oldoni, E. (2) 353–357
Arquizan, C., see Renard, D. (3) 759–764
Arrey, T.N., see Stockburger, C. (1) 201–215
Asada, T., see Takahashi, S. (3) 751–758
Ashby, E.L., J.S. Miners, P.G. Kehoe and S. Love, Effects of Hypertension and Anti-Hypertensive Treatment on Amy-loid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex (4) 1191–1203
Asthana, S., see Melah, K.E. (3) 873–886
Attems, J., see Vallortigara, J. (1) 101–110
Au, R., see Lebowitz, B.K. (1) 41–45
Auerbach, S., see Lebowitz, B.K. (1) 41–45
Auestad, B.H., see Vijayaraghavan, S. (2) 567–576
Avila, J., see Bolós, M. (1) 77–87
Avondino, E. and P. Antoine, Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer’s Disease (1) 89–99
Ayrignac, X., see Renard, D. (3) 759–764
Azakri, S., see Renard, D. (3) 759–764
Babić Leko, M., F. Boroveˇki, N. Dejanović, P.R. Hof and G. Šimić, Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment (3) 765–778
Bachman, A.H., see Ardekani, B.A. (3) 847–857
Baeumlisberger, M., see Stockburger, C. (1) 201–215
Baiardi, S., S. Capellari, A. Ladogana, S. Strumia, M. Santangelo, M. Pocchiari and P. Parchi, Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings (2) 465–476
Bak, H.-r., see Lim, S. (1) 189–200
Balietti, M., C. Giuli, P. Fattoretti, P. Fabbietti, D. Postacchini and F. Conti, Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment (4) 957–962
Ballard, C.G., see Vallortigara, J. (1) 101–110
Bao, M., see Shi, S. (3) 859–871
Barbeau, E.J., see Pistono, A. (3) 687–698
Barkhof, F., see Rhodius-Meester, H.F.M. (1) 261–270
Bartolotti, N., L. Segura and O. Lazarov, Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer’s Disease Mice (2) 477–489
Bateman, R.J., see Chatterjee, P. (3) 887–894
Baumann, M., see Tholen, S. (3) 791–796
Bavinck, C., see Claus, J.J. (3) 797–806
Bayer, T.A., see Weissmann, R. (2) 397–409
Becker, J.T., see Ibarria, M. (2) 559–566
Becker, J.T., see Kuźma, E. (4) 1099–1108
Beiser, A., see Lebowitz, B.K. (1) 41–45
Belkacemi, A. and C. Ramassamy, Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State (4) 981–998
Bendlin, B.B., see Melah, K.E. (3) 873–886
Benito-León, J., see Bermejo-Pareja, F. (3) 719–731
Benoit, S., see Langlois, R. (4) 1023–1033
Benussi, L., see Oldoni, E. (2) 353–357
Benzinger, T., see Chatterjee, P. (3) 887–894
Berge, G., see Vijayaraghavan, S. (2) 567–576
Bermejo-Pareja, F., I. Contador, R. Trincado, D. Lora, A. Sánchez-Ferro, A.J. Mitchell, E. Boycheva, A. Herrero, J. Hernández-Gallego, S. Llamas, A.V. Galende and J. Benito-León, Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort (3) 719–731
Bettarini, F., see Malara, A. (4) 1217–1225
Beyer, N., see Hoffmann, K. (2) 443–453
Bharadwaj, P., see Porter, T. (3) 895–905
Binetti, G., see Oldoni, E. (2) 353–357
Bittner, D., see Kleinschmidt, M. (1) 111–126
Bjerregaard, E., see Hoffmann, K. (2) 443–453
Blennow, K., see Melah, K.E. (3) 873–886
Blesa, R., see Carmona-Iragui, M. (1) 1–7
Blesa, R., see Morenas-Rodríguez, E. (2) 539–546
Blumen, H.M., see Wang, N. (3) 699–707
Boada, M., see Ibarria, M. (2) 559–566
Boccardi, V., C. Ruggiero, A. Patriti and L. Marano, Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer’s Disease (4) 947–955
Bocti, C., see Bourgade, K. (4) 1227–1241
Bogstedt, A., see Eketjäll, S. (4) 1109–1123
Bolós, M., M. Llorens-Martín, J. Jurado-Arjona, F. Hernández, A. Rábano and J. Avila, Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo (1) 77–87
Bonní, S., see Koch, G. (2) 605–616
Boroveˇki, F., see Babić Leko, M. (3) 765–778
Bouly, S., see Renard, D. (3) 759–764
Bourgade, K., A. Le Page, C. Bocti, J.M. Witkowski, G. Dupuis, E.H. Frost and T. Fülöp Jr., Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model (4) 1227–1241
Bouter, Y., see Weissmann, R. (2) 397–409
Boycheva, E., see Bermejo-Pareja, F. (3) 719–731
Bozzali, M., see Koch, G. (2) 605–616
Bozzali, M., see Makovac, E. (2) 591–604
Brændgaard, H., see Hoffmann, K. (2) 443–453
Bratzke, L.C., see Melah, K.E. (3) 873–886
Bravo-Caraduje, N., see Quintana-Hernández, D.J. (1) 217–232
Brisswalter, J., see Sacco, G. (1) 19–25
Brown, B.M., see Chatterjee, P. (3) 887–894
Bruno, G., see Oldoni, E. (2) 353–357
Buckley, A.H., see Hardy, C.J.D. (2) 359–371
Bucossi, S., see Siotto, M. (4) 1181–1189
Bursey, D., see Oldoni, E. (2) 353–357
Buschke, H., see Gramunt, N. (4) 999–1010
Cacciari, C., see Spalletta, G. (3) 807–816
Cacioppo, J.T., see Dodich, A. (4) 1011–1022
Cadenas, E., see Deochand, C. (2) 373–386
Cadenas, E., see Yu, R. (1) 133–148
Caillaud, C., see Sacco, G. (1) 19–25
Caltagirone, C., see Koch, G. (2) 605–616
Caltagirone, C., see Makovac, E. (2) 591–604
Caltagirone, C., see Spalletta, G. (3) 807–816
Calvet, B., see Pistono, A. (3) 687–698
Camacho, V., see Carmona-Iragui, M. (1) 1–7
Cañabate, P., see Ibarria, M. (2) 559–566
Canessa, N., see Dodich, A. (4) 1011–1022
Cao, X., see Jin, H. (2) 501–516
Cao, Y., see Hisatsune, T. (1) 149–159
Capellari, S., see Baiardi, S. (2) 465–476
Cappa, S.F., see Dodich, A. (4) 1011–1022
Caprara, D., see Siotto, M. (4) 1181–1189
Carlsson, C.M., see Melah, K.E. (3) 873–886
Carmona-Iragui, M., A. Fernández-Arcos, D. Alcolea, F. Piazza, E. Morenas-Rodriguez, S. Antón-Aguirre, I. Sala, J. Clarimon, O. Dols-Icardo, V. Camacho, F. Sampedro, J. Munuera, F. Nuñez-Marin, A. Lleó, J. Fortea, B. Gómez-Ansón and R. Blesa, Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation (1) 1–7
Carmona-Iragui, M., see Morenas-Rodríguez, E. (2) 539–546
Case, M., see Hochstetler, H. (1) 271–282
Casini, A.R., see Spalletta, G. (3) 807–816
Castro, L., see Fernández, G. (3) 827–838
Cebers, G., see Eketjäll, S. (4) 1109–1123
Cerami, C., see Dodich, A. (4) 1011–1022
Ceravolo, F., see Malara, A. (4) 1217–1225
Cercignani, M., see Makovac, E. (2) 591–604
Cervera-Carles, L., see Morenas-Rodríguez, E. (2) 539–546
Cha, J., see Kim, H.J. (3) 709–718
Chakrabarti, M., A.J. McDonald, J.W. Reed, M.A. Moss, B.C. Das and S.K. Ray, Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease (2) 335–352
Chang, Y.-L., Y.-S. Yen, T.-F. Chen, S.-H. Yan and W.-Y.I. Tseng, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer’s Disease (2) 411–423
Charidimou, A., Cerebral Amyloid Angiopathy-Related Inflammation Biomarkers: Where are we Now? (1) 9–11
Charif, M., see Renard, D. (3) 759–764
Chatterjee, P., W.L.F. Lim, G. Shui, V.B. Gupta, I. James, A.M. Fagan, C. Xiong, H.R. Sohrabi, K. Taddei, B.M. Brown, T. Benzinger, C. Masters, S.G. Snowden, M.R. Wenk, R.J. Bateman, J.C. Morris and R.N. Martins, Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study (3) 887–894
Chaves, P.H.M., see Kuźma, E. (4) 1099–1108
Chen, L., see Jin, H. (2) 501–516
Chen, T., see Jin, H. (2) 501–516
Chen, T.-F., see Chang, Y.-L. (2) 411–423
Chettle, D.R., see Mohseni, H.K. (4) 913–926
Chiang, H.-S., see Mudar, R.A. (2) 577–590
Chiapponi, C., see Spalletta, G. (3) 807–816
Chiu, P.-Y., see Li, H.-H. (4) 1083–1098
Chmielewski, S., see Tholen, S. (3) 791–796
Choe, Y.S., see Kim, H.J. (3) 709–718
Choi, J.G., see Lim, S. (1) 189–200
Clarimon, J., see Carmona-Iragui, M. (1) 1–7
Clarimón, J., see Morenas-Rodríguez, E. (2) 539–546
Claus, J.J., S.S. Staekenborg, J.J. Roorda, M. Stevens, D. Herderschee, W. van Maarschalkerweerd, L. Schuurmans, C.E.M. Tielkes, P. Koster, C. Bavinck and P. Scheltens, Low Prevalence of Mixed Dementia in a Cohort of 2,000 Elderly Patients in a Memory Clinic Setting (3) 797–806
Comijs, H., see Kuźma, E. (4) 1099–1108
Confaloni, A., see Oldoni, E. (2) 353–357
Contador, I., see Bermejo-Pareja, F. (3) 719–731
Conti, F., see Balietti, M. (4) 957–962
Convit, A., see Ardekani, B.A. (3) 847–857
Cotman, C.W., see Hoffmann, K. (2) 443–453
Cravello, L., see Spalletta, G. (3) 807–816
Crespi, C., see Dodich, A. (4) 1011–1022
Crutch, S.J., see Hardy, C.J.D. (2) 359–371
Cruz-Orduña, I., see Lacalle-Aurioles, M. (4) 1051–1064
Cui, Z., see Gao, L. (1) 13–17
Cutter, G.R., see Kennedy, R.E. (4) 1205–1215
Darby, D., see Takahashi, S. (3) 751–758
Darreh-Shori, T., see Vijayaraghavan, S. (2) 567–576
Das, B.C., see Chakrabarti, M. (2) 335–352
David, R., see Sacco, G. (1) 19–25
De Biase, G.A., see Malara, A. (4) 1217–1225
de Jager, C.A., see Oulhaj, A. (2) 547–557
de la Monte, S.M. see Deochand, C. (2) 373–386
de la Monte, S.M., see Yu, R. (1) 133–148
Deeg, D.J.H., see Kuźma, E. (4) 1099–1108
Degenhardt, E., see Hochstetler, H. (1) 271–282
Dejanović, N., see Babić Leko, M. (3) 765–778
del Carmen Pérez-Vieitez, M., see Quintana-Hernández, D.J. (1) 217–232
Demuth, H.-U., see Kleinschmidt, M. (1) 111–126
Deng, F., see Zhu, M. (4) 1149–1162
Deochand, C., M. Tong, A.R. Agarwal, E. Cadenas and S.M. de la Monte, Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration (2) 373–386
Deochand, C., see Yu, R. (1) 133–148
Dermody, N., M. Hornberger, O. Piguet, J.R. Hodges and M. Irish, Prospective Memory Impairments in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates (2) 425–441
Desco, M., see Lacalle-Aurioles, M. (4) 1051–1064
Destiche, D.J., see Melah, K.E. (3) 873–886
Di Cello, S., see Malara, A. (4) 1217–1225
Di Lorenzo, F., see Koch, G. (2) 605–616
Diego, S., see Ibarria, M. (2) 559–566
Dodich, A., C. Cerami, C. Crespi, N. Canessa, G. Lettieri, S. Iannaccone, A. Marcone, S.F. Cappa and J.T. Cacioppo, Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment (4) 1011–1022
Dols-Icardo, O., see Carmona-Iragui, M. (1) 1–7
Dols-Icardo, O., see Morenas-Rodríguez, E. (2) 539–546
Dostie, V., see Langlois, R. (4) 1023–1033
Dowling, N.M., see Melah, K.E. (3) 873–886
Downey, L.E., see Hardy, C.J.D. (2) 359–371
Dupuis, G., see Bourgade, K. (4) 1227–1241
Dziedzic, T., J. Pera, A. Klimkowicz-Mrowiec, B. Mroczko and A. Slowik, Biochemical and Radiological Markers of Alzheimer’s Disease Progression (3) 623–644
Eichler, T., see Michalowsky, B. (1) 47–59
Eketjäll, S., J. Janson, K. Kaspersson, A. Bogstedt, F. Jeppsson, J. Fälting, S.B. Haeberlein, A.R. Kugler, R.C. Alexander and G. Cebers, AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics (4) 1109–1123
Endres, K., see Schuck, F. (3) 817–826
Eroh, J., see Mudar, R.A. (2) 577–590
Eustache, P., F. Nemmi, L. Saint-Aubert, J. Pariente and P. Péran, Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage (4) 1035–1050
Ezra, A., I. Rabinovich-Nikitin, P. Rabinovich-Toidman and B. Solomon, Multifunctional Effect of Human Serum Albumin Reduces Alzheimer’s Disease Related Pathologies in the 3xTg Mouse Model (1) 175–188
Fabbietti, P., see Balietti, M. (4) 957–962
Fadda, L., see Marra, C. (1) 61–70
Fagan, A.M., see Chatterjee, P. (3) 887–894
Fälting, J., see Eketjäll, S. (4) 1109–1123
Fattoretti, P., see Balietti, M. (4) 957–962
Fauria, K., see Gramunt, N. (4) 999–1010
Fellgiebel, A., see Schuck, F. (3) 817–826
Fenoglio, C., see Oldoni, E. (2) 353–357
Fernandez del Olmo, M., see Koch, G. (2) 605–616
Fernández, G., F. Manes, L.E. Politi, D. Orozco, M. Schumacher, L. Castro, O. Agamennoni and N.P. Rotstein, Patients with Mild Alzheimer’s Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique (3) 827–838
Fernández-Arcos, A., see Carmona-Iragui, M. (1) 1–7
Fischer, C.E., W. Qian, T.A. Schweizer, C.P. Millikin, Z. Ismail, E.E. Smith, L.M. Lix, P. Shelton and D.G. Munoz, Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer’s Disease (1) 283–295
Flessa, S., see Michalowsky, B. (1) 47–59
Förstl, H., see Tholen, S. (3) 791–796
Fortea, J., see Carmona-Iragui, M. (1) 1–7
Fortea, J., see Morenas-Rodríguez, E. (2) 539–546
Fourcade, G., see Renard, D. (3) 759–764
Francis, P.T., see Vallortigara, J. (1) 101–110
Fratangeli, C., see Spalletta, G. (3) 807–816
Frederiksen, K.S., see Hoffmann, K. (2) 443–453
Friedland, K., see Stockburger, C. (1) 201–215
Frost, E.H., see Bourgade, K. (4) 1227–1241
Fujita, K., see Yasue, I. (3) 733–740
Fujiwara, H., see Yamashita, S. (2) 527–537
Fülöp Jr., T., see Bourgade, K. (4) 1227–1241
Fumagalli, G.G., see Oldoni, E. (2) 353–357
Furukawa, K., see Yamashita, S. (2) 527–537
Gabelle, A., see Renard, D. (3) 759–764
Gainotti, G., see Marra, C. (1) 61–70
Galende, A.V., see Bermejo-Pareja, F. (3) 719–731
Galimberti, D., see Oldoni, E. (2) 353–357
Gallucci, M., P. Spagnolo, M. Aricò and E. Grossi, Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer’s Disease: Date Mining from the TREDEM Registry (4) 969–979
Gao, L., Z. Cui, L. Shen and H.-F. Ji, Shared Genetic Etiology between Type 2 Diabetes and Alzheimer’s Disease Identified by Bioinformatics Analysis (1) 13–17
Gao, Q., see Lim, S.L. (1) 27–40
Gardener, S.L., S.R. Rainey-Smith and R.N. Martins, Diet and Inflammation in Alzheimer’s Disease and Related Chronic Diseases: A Review (2) 301–334
Garo, M., see Malara, A. (4) 1217–1225
Geng, S., see Zhu, M. (4) 1149–1162
Gergelyffy, R.G., see Hoffmann, K. (2) 443–453
Ghidoni, R., see Oldoni, E. (2) 353–357
Gianni, W., see Spalletta, G. (3) 807–816
Gispert, J.D., see Gramunt, N. (4) 999–1010
Giuli, C., see Balietti, M. (4) 957–962
Giulietti, G., see Makovac, E. (2) 591–604
Glabe, C., see Hatami, A. (2) 517–525
Gleason, C.E., see Melah, K.E. (3) 873–886
Goldstein, F.C., see Steenland, K. (1) 71–76
Gómez-Ansón, B., see Carmona-Iragui, M. (1) 1–7
Gong, L., see Lim, S.L. (1) 27–40
Göttlich, C., see Kleinschmidt, M. (1) 111–126
Gottrup, H., see Hoffmann, K. (2) 443–453
Gozes, I., see Malishkevich, A. (1) 249–260
Gramunt, N., G. Sánchez-Benavides, H. Buschke, R.B. Lipton, X. Masramon, J.D. Gispert, J. Peña-Casanova, K. Fauria and J.L. Molinuevo, Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity (4) 999–1010
Grande, G., see Oldoni, E. (2) 353–357
Grimmer, T., see Tholen, S. (3) 791–796
Grossi, E., see Gallucci, M. (4) 969–979
Groth, D., see Porter, T. (3) 895–905
Gu, Q., see Luo, X. (4) 1137–1148
Guan, X., see Luo, X. (4) 1137–1148
Guitart, M., see Ibarria, M. (2) 559–566
Gupta, V.B., see Chatterjee, P. (3) 887–894
Guzmán-De-Villoria, J.A., see Lacalle-Aurioles, M. (4) 1051–1064
Haeberlein, S.B., see Eketjäll, S. (4) 1109–1123
Han, C.E., see Jung, N.-Y. (4) 1125–1135
Hardy, C.J.D., A.H. Buckley, L.E. Downey, M. Lehmann, V.C. Zimmerer, R.A. Varley, S.J. Crutch, J.D. Rohrer, E.K. Warrington and J.D. Warren, The Language Profile of Behavioral Variant Frontotemporal Dementia (2) 359–371
Hart Jr., J., see Mudar, R.A. (2) 577–590
Hashimoto, M., see Yamashita, S. (2) 527–537
Hasselbalch, S.G., see Hoffmann, K. (2) 443–453
Hatami, A., S. Monjazeb and C. Glabe, The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils (2) 517–525
Hattori, S., see Takahashi, S. (3) 751–758
Hayashi, S., see Nagata, T. (3) 839–845
Heemann, U., see Tholen, S. (3) 791–796
Henley, D.B., see Hochstetler, H. (1) 271–282
Henley, W.E., see Kuźma, E. (4) 1099–1108
Herderschee, D., see Claus, J.J. (3) 797–806
Hernández, F., see Bolós, M. (1) 77–87
Hernández, I., see Ibarria, M. (2) 559–566
Hernández, J., see Ibarria, M. (2) 559–566
Hernández-Gallego, J., see Bermejo-Pareja, F. (3) 719–731
Herrero, A., see Bermejo-Pareja, F. (3) 719–731
Hertel, J., see Michalowsky, B. (1) 47–59
Hirtz, C., see Renard, D. (3) 759–764
Hisatsune, T., J. Kaneko, H. Kurashige, Y. Cao, H. Satsu, M. Totsuka, Y. Katakura, E. Imabayashi and H. Matsuda, Effect of Anserine/Carnosine Supplementation on Verbal Episodic Memory in Elderly People (1) 149–159
Ho, J., see Nation, D.A. (3) 779–789
Hochstetler, H., P.T. Trzepacz, S. Wang, P. Yu, M. Case, D.B. Henley, E. Degenhardt, J.-M. Leoutsakos and C.G. Lyketsos for the Alzheimer’s Disease Neuroimaging Initiative, Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline (1) 271–282
Hodges, J.R., see Dermody, N. (2) 425–441
Hof, P.R., see Babić Leko, M. (3) 765–778
Hoffmann, K., N.A. Sobol, K.S. Frederiksen, N. Beyer, A. Vogel, K. Vestergaard, H. Brændgaard, H. Gottrup, A. Lolk, L. Wermuth, S. Jacobsen, L.P. Laugesen, R.G. Gergelyffy, P. Høgh, E. Bjerregaard, B.B. Andersen, V. Siersma, P. Johannsen, C.W. Cotman, G. Waldemar and S.G. Hasselbalch, Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial (2) 443–453
Hoffmann, W., see Michalowsky, B. (1) 47–59
Høgh, P., see Hoffmann, K. (2) 443–453
Honkura, K., see Sugiyama, K. (2) 491–500
Hornberger, M., see Dermody, N. (2) 425–441
Hort, J., see Ni, L. (4) 1243–1254
Hortobágyi, T., see Vallortigara, J. (1) 101–110
Hoscheidt, S.M., see Melah, K.E. (3) 873–886
Howlett, D., see Vallortigara, J. (1) 101–110
Hu, X., see Huang, F. (3) 659–667
Huang, C., see Zhu, M. (4) 1149–1162
Huang, C.-N., see Li, H.-H. (4) 1083–1098
Huang, F., Y. Shang, Y. Luo, P. Wu, X. Huang, X. Tan, X. Lu, L. Zhen and X. Hu, Lower Prevalence of Alzheimer’s Disease among Tibetans: Association with Religious and Genetic Factors (3) 659–667
Huang, P., see Luo, X. (4) 1137–1148
Huang, W.-N., see Li, H.-H. (4) 1083–1098
Huang, X., see Huang, F. (3) 659–667
Hüttenrauch, M., see Weissmann, R. (2) 397–409
Iannaccone, S., see Dodich, A. (4) 1011–1022
Ibáñez-Fernández, I.J., see Quintana-Hernández, D.J. (1) 217–232
Ibarria, M., M. Alegret, S. Valero, A. Morera, M. Guitart, P. Cañabate, M. Moreno, S. Lara, S. Diego, J. Hernández, N. Tantinyá, M. Vera, I. Hernández, J.T. Becker, A. Ruíz, M. Boada and L. Tárraga for the Fundació ACE Alzheimer Research Center and Memory Clinic, Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer’s Disease (2) 559–566
Imabayashi, E., see Hisatsune, T. (1) 149–159
Iorio, M., see Spalletta, G. (3) 807–816
Irish, M., see Dermody, N. (2) 425–441
Ismail, Z., see Fischer, C.E. (1) 283–295
Ito, K., see Mishima, A. (1) 161–174
Iwata, N., see Yasue, I. (3) 733–740
Jacobsen, S., see Hoffmann, K. (2) 443–453
Jagust, W.J., see Jung, N.-Y. (4) 1125–1135
James, I., see Chatterjee, P. (3) 887–894
Janson, J., see Eketjäll, S. (4) 1109–1123
Jeppsson, F., see Eketjäll, S. (4) 1109–1123
Jernerén, F., see Oulhaj, A. (2) 547–557
Ji, H.-F., see Gao, L. (1) 13–17
Jia, Y., see Luo, X. (4) 1137–1148
Jiang, Y., see Zhu, M. (4) 1149–1162
Jin, H., T. Chen, G. Li, C. Wang, B. Zhang, X. Cao, S. Sha, Q. Wan and L. Chen, Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ1-42 (2) 501–516
Johannsen, P., see Hoffmann, K. (2) 443–453
Johnson, M., see Vallortigara, J. (1) 101–110
Johnson, S.C., see Melah, K.E. (3) 873–886
Joubert, S., see Langlois, R. (4) 1023–1033
Jucla, M., see Pistono, A. (3) 687–698
Jung, N.-Y., C.E. Han, H.J. Kim, S.W. Yoo, H.-J. Kim, E.-J. Kim, D.L. Na, S.N. Lockhart, W.J. Jagust, J.-K. Seong and S.W. Seo, Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment (4) 1125–1135
Jung, N.-Y., see Kim, H.J. (3) 709–718
Jurado-Arjona, J., see Bolós, M. (1) 77–87
Kacprowski, T., see Weissmann, R. (2) 397–409
Kaiho, Y., see Sugiyama, K. (2) 491–500
Kaneko, J., see Hisatsune, T. (1) 149–159
Karas, M., see Stockburger, C. (1) 201–215
Kaspersson, K., see Eketjäll, S. (4) 1109–1123
Katakura, Y., see Hisatsune, T. (1) 149–159
Kato, T., see Mishima, A. (1) 161–174
Kauwe, J.S., see Oldoni, E. (2) 353–357
Kawai, H., see Mishima, A. (1) 161–174
Kehoe, P.G., see Ashby, E.L. (4) 1191–1203
Kennedy, R.E., G.R. Cutter, G. Wang and L.S. Schneider, Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials (4) 1205–1215
Kesavadas, C., see Wang, N. (3) 699–707
Kestenbaum, B.R., see Kuźma, E. (4) 1099–1108
Kiko, T., see Yamashita, S. (2) 527–537
Kikuchi, N., see Takahashi, S. (3) 751–758
Kim, E.-J., see Jung, N.-Y. (4) 1125–1135
Kim, H.G., see Lim, S. (1) 189–200
Kim, H.J., J. Cha, J.-M. Lee, J.S. Shin, N.-Y. Jung, Y.J. Kim, Y.S. Choe, K.H. Lee, S.T. Kim, J.S. Kim, J.H. Lee, D.L. Na and S.W. Seo, Distinctive Resting State Network Disruptions Among Alzheimer’s Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients (3) 709–718
Kim, H.J., see Jung, N.-Y. (4) 1125–1135
Kim, H.-J., see Jung, N.-Y. (4) 1125–1135
Kim, J.S., see Kim, H.J. (3) 709–718
Kim, S.T., see Kim, H.J. (3) 709–718
Kim, S.Y., see Lim, S. (1) 189–200
Kim, Y.J., see Kim, H.J. (3) 709–718
Kinoshita, M., see Yamashita, S. (2) 527–537
Kishi, T., see Yasue, I. (3) 733–740
Klarin, I., see Wimo, A. (2) 387–396
Kleinschmidt, M., R. Schoenfeld, C. Göttlich, D. Bittner, J.E. Metzner, B. Leplow and H.-U. Demuth, Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology (1) 111–126
Klimkowicz-Mrowiec, A., see Dziedzic, T. (3) 623–644
Koch, G., F. Di Lorenzo, M. Fernandez del Olmo, S. Bonní, V. Ponzo, C. Caltagirone, M. Bozzali and A. Martorana, Reversal of LTP-Like Cortical Plasticity in Alzheimer’s Disease Patients with Tau-Related Faster Clinical Progression (2) 605–616
Koikkalainen, J., see Rhodius-Meester, H.F.M. (1) 261–270
Kokjohn, T.A., see Roher, A.E. (3) 645–658
Köpke, B., see Pistono, A. (3) 687–698
Koster, P., see Claus, J.J. (3) 797–806
Kraut, M.A., see Mudar, R.A. (2) 577–590
Krotow, A., see Yu, R. (1) 133–148
Kugler, A.R., see Eketjäll, S. (4) 1109–1123
Kuller, L.H., see Kuźma, E. (4) 1099–1108
Kung, F., see Mudar, R.A. (2) 577–590
Kurashige, H., see Hisatsune, T. (1) 149–159
Kuss, A.W., see Weissmann, R. (2) 397–409
Kuźma, E., M. Soni, T.J. Littlejohns, J.M. Ranson, N.M. van Schoor, D.J.H. Deeg, H. Comijs, P.H.M. Chaves, B.R. Kestenbaum, L.H. Kuller, O.L. Lopez, J.T. Becker, K.M. Langa, W.E. Henley, I.A. Lang, O.C. Ukoumunne and D.J. Llewellyn, Vitamin D and Memory Decline: Two Population-Based Prospective Studies (4) 1099–1108
Lacalle-Aurioles, M., F.J. Navas-Sánchez, Y. Alemán-Gómez, J. Olazarán, J.A. Guzmán-De-Villoria, I. Cruz-Orduña, J.M. Mateos-Pérez and M. Desco, The Disconnection Hypothesis in Alzheimer’s Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging (4) 1051–1064
Lacidogna, G., see Marra, C. (1) 61–70
Ladogana, A., see Baiardi, S. (2) 465–476
Lai, T.-J., see Li, H.-H. (4) 1083–1098
Lang, I.A., see Kuźma, E. (4) 1099–1108
Langa, K.M., see Kuźma, E. (4) 1099–1108
Langlois, R., S. Joubert, S. Benoit, V. Dostie and I. Rouleau, Memory for Public Events in Mild Cognitive Impairment and Alzheimer’s Disease: The Importance of Rehearsal (4) 1023–1033
Lara, S., see Ibarria, M. (2) 559–566
Laugesen, L.P., see Hoffmann, K. (2) 443–453
Laws, S.M., see Porter, T. (3) 895–905
Lazarov, O., see Bartolotti, N. (2) 477–489
Le Floch, A., see Renard, D. (3) 759–764
Le Page, A., see Bourgade, K. (4) 1227–1241
Le, W., see Qiu, H. (3) 669–685
Leão, R., see Yu, R. (1) 133–148
Lebowitz, B.K., C. Weinstein, A. Beiser, S. Seshadri, P.A. Wolf, S. Auerbach and R. Au, Lifelong Reading Disorder and Mild Cognitive Impairment: Implications for Diagnosis (1) 41–45
Lee, J.H., see Kim, H.J. (3) 709–718
Lee, J.-M., see Kim, H.J. (3) 709–718
Lee, K.H., see Kim, H.J. (3) 709–718
Lee, W., see Lim, S. (1) 189–200
Lehmann, M., see Hardy, C.J.D. (2) 359–371
Lehmann, S., see Renard, D. (3) 759–764
Lemesle, B., see Pistono, A. (3) 687–698
Lemstra, A.W., see Rhodius-Meester, H.F.M. (1) 261–270
Leoutsakos, J.-M., see Hochstetler, H. (1) 271–282
Leplow, B., see Kleinschmidt, M. (1) 111–126
Lettieri, G., see Dodich, A. (4) 1011–1022
Levey, A., see Steenland, K. (1) 71–76
Li, G., see Jin, H. (2) 501–516
Li, H., see Zhang, T. (2) 455–463
Li, H.-H., S.-L. Lin, C.-N. Huang, F.-J. Lu, P.-Y. Chiu, W.-N. Huang, T.-J. Lai and C.-L. Lin, miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling (4) 1083–1098
Li, M., see Ni, L. (4) 1243–1254
Li, S., see Qiu, H. (3) 669–685
Li, X., see Zhang, T. (2) 455–463
Li, X., see Zhu, M. (4) 1149–1162
Liang, D., see Shi, S. (3) 859–871
Liang, Z., see Zhu, M. (4) 1149–1162
Lim, M.L., see Lim, S.L. (1) 27–40
Lim, S., J.G. Choi, M. Moon, H.G. Kim, W. Lee, H.-r. Bak, H. Sung, C.H. Park, S.Y. Kim and M.S. Oh, An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice (1) 189–200
Lim, S.L., Q. Gao, M.S.Z. Nyunt, L. Gong, J.B. Lunaria, M.L. Lim, A. Ling, C. Su-Ping Lam, A.M. Richards, L.H. Ling and T.P. Ng, Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies (1) 27–40
Lim, W.L.F., see Chatterjee, P. (3) 887–894
Lim, Y.Y., see Santos, C.Y. (1) 127–131
Lin, C.-L., see Li, H.-H. (4) 1083–1098
Lin, S.-L., see Li, H.-H. (4) 1083–1098
Ling, A., see Lim, S.L. (1) 27–40
Ling, L.H., see Lim, S.L. (1) 27–40
Lipton, R.B., see Gramunt, N. (4) 999–1010
Littlejohns, T.J., see Kuźma, E. (4) 1099–1108
Liu, G., see Wang, S. (1) 233–248
Liu, H., see Qiu, H. (3) 669–685
Liu, R., see Ni, L. (4) 1243–1254
Lix, L.M., see Fischer, C.E. (1) 283–295
Llamas, S., see Bermejo-Pareja, F. (3) 719–731
Lleó, A., see Carmona-Iragui, M. (1) 1–7
Lleó, A., see Morenas-Rodríguez, E. (2) 539–546
Llewellyn, D.J., see Kuźma, E. (4) 1099–1108
Llorens-Martín, M., see Bolós, M. (1) 77–87
Lockhart, S.N., see Jung, N.-Y. (4) 1125–1135
Lolk, A., see Hoffmann, K. (2) 443–453
Lopez, O.L., see Kuźma, E. (4) 1099–1108
Lora, D., see Bermejo-Pareja, F. (3) 719–731
Lötjönen, J., see Rhodius-Meester, H.F.M. (1) 261–270
Love, S., see Ashby, E.L. (4) 1191–1203
Lu, F.-J., see Li, H.-H. (4) 1083–1098
Lu, X., see Huang, F. (3) 659–667
Lunaria, J.B., see Lim, S.L. (1) 27–40
Luo, X., T. Qiu, X. Xu, P. Huang, Q. Gu, Z. Shen, X. Yu, Y. Jia, X. Guan, R. Song, M. Zhang and for the Alzheimer’s Disease Neuroimaging Initiative, Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study (4) 1137–1148
Luo, Y., see Huang, F. (3) 659–667
Lyketsos, C.G. see Hochstetler, H. (1) 271–282
Ma, X., see Zhu, M. (4) 1149–1162
Maarouf, C.L., see Roher, A.E. (3) 645–658
Machan, J.T., see Santos, C.Y. (1) 127–131
Maes, A., R. Anthonissen, S. Wambacq, K. Simons and L. Verschaeve, The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer’s Disease (3) 741–749
Maguire, M.J., see Mudar, R.A. (2) 577–590
Makovac, E., L. Serra, B. Spanò, G. Giulietti, M. Torso, M. Cercignani, C. Caltagirone and M. Bozzali, Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer’s Disease (2) 591–604
Malara, A., G.A. De Biase, F. Bettarini, F. Ceravolo, S. Di Cello, M. Garo, F. Praino, V. Settembrini, G. Sgrò, F. Spadea and V. Rispoli, Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia (4) 1217–1225
Malishkevich, A., G.A. Marshall, A.P. Schultz, R.A. Sperling, J. Aharon-Peretz and I. Gozes, Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer’s Disease Biomarkers (1) 249–260
Manes, F., see Fernández, G. (3) 827–838
Marano, L., see Boccardi, V. (4) 947–955
Marcone, A., see Dodich, A. (4) 1011–1022
Marelli, C., see Renard, D. (3) 759–764
Mari, D., see Oldoni, E. (2) 353–357
Mariani, C., see Oldoni, E. (2) 353–357
Mariani, S., see Siotto, M. (4) 1181–1189
Marra, C., G. Gainotti, L. Fadda, R. Perri, G. Lacidogna, E. Scaricamazza, C. Piccininni and D. Quaranta, Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Episodic Memory Score (EMS) (1) 61–70
Marshall, G.A., see Malishkevich, A. (1) 249–260
Martins, R.N., see Chatterjee, P. (3) 887–894
Martins, R.N., see Gardener, S.L. (2) 301–334
Martins, R.N., see Porter, T. (3) 895–905
Martorana, A., see Koch, G. (2) 605–616
Maruff, P., see Santos, C.Y. (1) 127–131
Masramon, X., see Gramunt, N. (4) 999–1010
Masters, C., see Chatterjee, P. (3) 887–894
Mateos-Pérez, J.M., see Lacalle-Aurioles, M. (4) 1051–1064
Matsuda, H., see Hisatsune, T. (1) 149–159
Matsunaga, S., see Yasue, I. (3) 733–740
Mattila, J., see Rhodius-Meester, H.F.M. (1) 261–270
McDonald, A.J., see Chakrabarti, M. (2) 335–352
Melah, K.E., S. Yuan-Fu Lu, S.M. Hoscheidt, A.L. Alexander, N. Adluru, D.J. Destiche, C.M. Carlsson, H. Zetterberg, K. Blennow, O.C. Okonkwo, C.E. Gleason, N.M. Dowling, L.C. Bratzke, H.A. Rowley, M.A. Sager, S. Asthana, S.C. Johnson and B.B. Bendlin, Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease (3) 873–886
Metzner, J.E., see Kleinschmidt, M. (1) 111–126
MG Cioffi, S., see Oldoni, E. (2) 353–357
Miano, D., see Stockburger, C. (1) 201–215
Michalowsky, B., J.R. Thyrian, T. Eichler, J. Hertel, D. Wucherer, S. Flessa and W. Hoffmann, Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany (1) 47–59
Mihashi, Y., see Nagata, T. (3) 839–845
Millikin, C.P., see Fischer, C.E. (1) 283–295
Mimura, M., see Nagata, T. (3) 839–845
Miners, J.S., see Ashby, E.L. (4) 1191–1203
Miró-Barrachina, M.T., see Quintana-Hernández, D.J. (1) 217–232
Mishima, A., T. Nihashi, Y. Ando, H. Kawai, T. Kato, K. Ito and T. Terasawa, Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis (1) 161–174
Mitchell, A.J., see Bermejo-Pareja, F. (3) 719–731
Miyazawa, T., see Yamashita, S. (2) 527–537
Mizukami, K., see Takahashi, S. (3) 751–758
Mohseni, H.K. and D.R. Chettle, A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects (4) 913–926
Molinario, R., see Siotto, M. (4) 1181–1189
Molinuevo, J.L., see Gramunt, N. (4) 999–1010
Monjazeb, S., see Hatami, A. (2) 517–525
Moon, M., see Lim, S. (1) 189–200
Morales-Casanova, D., see Quintana-Hernández, D.J. (1) 217–232
Morenas-Rodríguez, E., L. Cervera-Carles, E. Vilaplana, D. Alcolea, M. Carmona-Iragui, O. Dols-Icardo, R. Ribosa-Nogué, L. Muñoz-Llahuna, I. Sala, M.B. Sánchez-Saudinós, R. Blesa, J. Clarimón, J. Fortea and A. Lleó, Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias (2) 539–546
Morenas-Rodriguez, E., see Carmona-Iragui, M. (1) 1–7
Moreno, M., see Ibarria, M. (2) 559–566
Morera, A., see Ibarria, M. (2) 559–566
Morris, J.C., see Chatterjee, P. (3) 887–894
Moss, M.A., see Chakrabarti, M. (2) 335–352
Mroczko, B., see Dziedzic, T. (3) 623–644
Mudar, R.A., H.-S. Chiang, J. Eroh, L.T. Nguyen, M.J. Maguire, J.S. Spence, F. Kung, M.A. Kraut and J. Hart Jr., The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials (2) 577–590
Müller, W.E., see Stockburger, C. (1) 201–215
Munoz, D.G., see Fischer, C.E. (1) 283–295
Muñoz-Llahuna, L., see Morenas-Rodríguez, E. (2) 539–546
Munuera, J., see Carmona-Iragui, M. (1) 1–7
Na, D.L., see Jung, N.-Y. (4) 1125–1135
Na, D.L., see Kim, H.J. (3) 709–718
Nacmias, B., see Oldoni, E. (2) 353–357
Nagata, T., S. Shinagawa, S. Nakajima, E. Plitman, Y. Mihashi, S. Hayashi, M. Mimura and K. Nakayama, Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer’s Disease: Analysis of the CATIE-AD Study (3) 839–845
Nakagawa, K., see Yamashita, S. (2) 527–537
Nakajima, S., see Nagata, T. (3) 839–845
Nakayama, K., see Nagata, T. (3) 839–845
Nation, D.A., J. Ho, B. Yew and for the Alzheimer’s Disease Neuroimaging Initiative, Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention (3) 779–789
Navas-Sánchez, F.J., see Lacalle-Aurioles, M. (4) 1051–1064
Nedelska, Z., see Ni, L. (4) 1243–1254
Nemmi, F., see Eustache, P. (4) 1035–1050
Ng, T.P., see Lim, S.L. (1) 27–40
Nguyen, L.T., see Mudar, R.A. (2) 577–590
Ni, L., R. Liu, Z. Yin, H. Zhao, Z. Nedelska, J. Hort, F. Zhou, W. Wu, X. Zhang, M. Li, H. Yu, B. Zhu, Y. Xu and B. Zhang, Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and Concomitant Lacunar Infarction: A Resting-State Functional MRI Study (4) 1243–1254
Nihashi, T., see Mishima, A. (1) 161–174
Noone, M.L., see Wang, N. (3) 699–707
Nordberg, G., see Wimo, A. (2) 387–396
Nuñez-Marin, F., see Carmona-Iragui, M. (1) 1–7
Nyunt, M.S.Z., see Lim, S.L. (1) 27–40
O’Brien, J.T., see Vallortigara, J. (1) 101–110
Ogawa, R., see Takahashi, S. (3) 751–758
Oh, M.S., see Lim, S. (1) 189–200
Okonkwo, O.C., see Melah, K.E. (3) 873–886
Olazarán, J., see Lacalle-Aurioles, M. (4) 1051–1064
Oldoni, E., G.G. Fumagalli, M. Serpente, C. Fenoglio, M. Scarioni, A. Arighi, G. Bruno, G. Talarico, A. Confaloni, P. Piscopo, B. Nacmias, S. Sorbi, I. Rainero, E. Rubino, L. Pinessi, G. Binetti, R. Ghidoni, L. Benussi, G. Grande, B. Arosio, D. Bursey, J.S. Kauwe, S. MG Cioffi, M. Arcaro, D. Mari, C. Mariani, E. Scarpini and D. Galimberti, PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population (2) 353–357
Orfei, M.D., see Spalletta, G. (3) 807–816
Orozco, D., see Fernández, G. (3) 827–838
Oulhaj, A., F. Jernerén, H. Refsum, A.D. Smith and C.A. de Jager, Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment (2) 547–557
Pallas, T., see Stockburger, C. (1) 201–215
Parchi, P., see Baiardi, S. (2) 465–476
Pariente, J., see Eustache, P. (4) 1035–1050
Pariente, J., see Pistono, A. (3) 687–698
Park, C.H., see Lim, S. (1) 189–200
Pasqualetti, P., see Siotto, M. (4) 1181–1189
Patriti, A., see Boccardi, V. (4) 947–955
Paxman, A., see Porter, T. (3) 895–905
Peña-Casanova, J., see Gramunt, N. (4) 999–1010
Pera, J., see Dziedzic, T. (3) 623–644
Péran, P., see Eustache, P. (4) 1035–1050
Perri, R., see Marra, C. (1) 61–70
Phillips, P., see Wang, S. (1) 233–248
Phillips, P., see Zhang, Y. (4) 1163–1179
Piazza, F., see Carmona-Iragui, M. (1) 1–7
Piccininni, C., see Marra, C. (1) 61–70
Piguet, O., see Dermody, N. (2) 425–441
Pinessi, L., see Oldoni, E. (2) 353–357
Piras, F., see Spalletta, G. (3) 807–816
Piras, F., see Spalletta, G. (3) 807–816
Piscopo, P., see Oldoni, E. (2) 353–357
Pistono, A., M. Jucla, E.J. Barbeau, L. Saint-Aubert, B. Lemesle, B. Calvet, B. Köpke, M. Puel and J. Pariente, Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer’s Disease (3) 687–698
Plitman, E., see Nagata, T. (3) 839–845
Pocchiari, M., see Baiardi, S. (2) 465–476
Politi, L.E., see Fernández, G. (3) 827–838
Polynice, S., see Santos, C.Y. (1) 127–131
Ponzo, V., see Koch, G. (2) 605–616
Porter, T., P. Bharadwaj, D. Groth, A. Paxman, S.M. Laws, R.N. Martins and G. Verdile, The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity (3) 895–905
Postacchini, D., see Balietti, M. (4) 957–962
Pradeep, V.G., see Wang, N. (3) 699–707
Pradier, L., see Weissmann, R. (2) 397–409
Praino, F., see Malara, A. (4) 1217–1225
Puel, M., see Pistono, A. (3) 687–698
Qi, D., see Zhang, T. (2) 455–463
Qian, W., see Fischer, C.E. (1) 283–295
Qiao, Z., see Shi, S. (3) 859–871
Qiu, C., see Wimo, A. (2) 387–396
Qiu, H., R. Zhong, H. Liu, F. Zhang, S. Li and W. Le, Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer’s Disease-Like Pathologies in AβPPswe/PS1ΔE9 Mice (3) 669–685
Qiu, T., see Luo, X. (4) 1137–1148
Quaranta, D., see Marra, C. (1) 61–70
Quelch, W., see Vallortigara, J. (1) 101–110
Quintana-Hernández, D.J., M.T. Miró-Barrachina, I.J. Ibáñez-Fernández, A. Santana-del Pino, M.P. Quintana-Montesdeoca, B. Rodríguez-de Vera, D. Morales-Casanova, M. del Carmen Pérez-Vieitez, J. Rodríguez-García and N. Bravo-Caraduje, Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer’s Disease: A Randomized Clinical Trial (1) 217–232
Quintana-Montesdeoca, M.P., see Quintana-Hernández, D.J. (1) 217–232
Rábano, A., see Bolós, M. (1) 77–87
Rabinovich-Nikitin, I., see Ezra, A. (1) 175–188
Rabinovich-Toidman, P., see Ezra, A. (1) 175–188
Rainero, I., see Oldoni, E. (2) 353–357
Rainey-Smith, S.R., see Gardener, S.L. (2) 301–334
Ramassamy, C., see Belkacemi, A. (4) 981–998
Ramirez, M.J., see Rodriguez-Perdigon, M. (4) 963–967
Ranson, J.M., see Kuźma, E. (4) 1099–1108
Ray, S.K., see Chakrabarti, M. (2) 335–352
Reed, J.W., see Chakrabarti, M. (2) 335–352
Refsum, H., see Oulhaj, A. (2) 547–557
Renard, D., A. Wacongne, X. Ayrignac, M. Charif, G. Fourcade, S. Azakri, A. Le Floch, S. Bouly, C. Marelli, C. Arquizan, C. Hirtz, A. Gabelle, E. Thouvenot and S. Lehmann, Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation (3) 759–764
Rhodius-Meester, H.F.M., J. Koikkalainen, J. Mattila, C.E. Teunissen, F. Barkhof, A.W. Lemstra, P. Scheltens, J. Lötjönen and W.M. van der Flier, Integrating Biomarkers for Underlying Alzheimer’s Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers (1) 261–270
Ribosa-Nogué, R., see Morenas-Rodríguez, E. (2) 539–546
Richards, A.M., see Lim, S.L. (1) 27–40
Rispoli, V., see Malara, A. (4) 1217–1225
Robert, P., see Sacco, G. (1) 19–25
Rodríguez-de Vera, B., see Quintana-Hernández, D.J. (1) 217–232
Rodríguez-García, J., see Quintana-Hernández, D.J. (1) 217–232
Rodriguez-Perdigon, M., M. Solas and M.J. Ramirez, JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer’s Disease (4) 963–967
Roher, A.E., C.L. Maarouf and T.A. Kokjohn, Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified? (3) 645–658
Rohrer, J.D., see Hardy, C.J.D. (2) 359–371
Rongioletti, M., see Siotto, M. (4) 1181–1189
Rongve, A., see Vijayaraghavan, S. (2) 567–576
Roorda, J.J., see Claus, J.J. (3) 797–806
Rossini,P.M., see Siotto, M. (4) 1181–1189
Rotstein, N.P., see Fernández, G. (3) 827–838
Rouleau, I., see Langlois, R. (4) 1023–1033
Rowley, H.A., see Melah, K.E. (3) 873–886
Rubino, E., see Oldoni, E. (2) 353–357
Ruggiero, C., see Boccardi, V. (4) 947–955
Ruíz, A., see Ibarria, M. (2) 559–566
Sacco, G., C. Caillaud, G.B. Sadoun, P. Robert, R. David and J. Brisswalter, Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment (1) 19–25
Sadoun, G.B., see Sacco, G. (1) 19–25
Sager, M.A., see Melah, K.E. (3) 873–886
Saint-Aubert, L., see Eustache, P. (4) 1035–1050
Saint-Aubert, L., see Pistono, A. (3) 687–698
Sala, I., see Carmona-Iragui, M. (1) 1–7
Sala, I., see Morenas-Rodríguez, E. (2) 539–546
Sampedro, F., see Carmona-Iragui, M. (1) 1–7
Sancesario, G., see Spalletta, G. (3) 807–816
Sánchez-Benavides, G., see Gramunt, N. (4) 999–1010
Sánchez-Ferro, A., see Bermejo-Pareja, F. (3) 719–731
Sánchez-Saudinós, M.B., see Morenas-Rodríguez, E. (2) 539–546
Sando, S.B., see Vijayaraghavan, S. (2) 567–576
Santana-del Pino, A., see Quintana-Hernández, D.J. (1) 217–232
Santangelo, M., see Baiardi, S. (2) 465–476
Santos, C.Y., Y.Y. Lim, W.-C. Wu, J.T. Machan, S. Polynice, R. Schindler, P. Maruff and P.J. Snyder, Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer’s Disease (1) 127–131
Satsu, H., see Hisatsune, T. (1) 149–159
Scaricamazza, E., see Marra, C. (1) 61–70
Scarioni, M., see Oldoni, E. (2) 353–357
Scarpini, E., see Oldoni, E. (2) 353–357
Scheltens, P., see Claus, J.J. (3) 797–806
Scheltens, P., see Rhodius-Meester, H.F.M. (1) 261–270
Schindler, R., see Santos, C.Y. (1) 127–131
Schmaderer, C., see Tholen, S. (3) 791–796
Schneider, L.S., see Kennedy, R.E. (4) 1205–1215
Schoenfeld, R., see Kleinschmidt, M. (1) 111–126
Schröter, F., see Wruck, W. (4) 1065–1082
Schuck, F., D. Wolf, A. Fellgiebel and K. Endres, Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging (3) 817–826
Schultz, A.P., see Malishkevich, A. (1) 249–260
Schumacher, M., see Fernández, G. (3) 827–838
Schuurmans, L., see Claus, J.J. (3) 797–806
Schweizer, T.A., see Fischer, C.E. (1) 283–295
Segura, L., see Bartolotti, N. (2) 477–489
Seo, S.W., see Jung, N.-Y. (4) 1125–1135
Seo, S.W., see Kim, H.J. (3) 709–718
Seong, J.-K., see Jung, N.-Y. (4) 1125–1135
Serpente, M., see Oldoni, E. (2) 353–357
Serra, L., see Makovac, E. (2) 591–604
Seshadri, S., see Lebowitz, B.K. (1) 41–45
Settembrini, V., see Malara, A. (4) 1217–1225
Sgrò, G., see Malara, A. (4) 1217–1225
Sha, S., see Jin, H. (2) 501–516
Shang, Y., see Huang, F. (3) 659–667
Shelton, P., see Fischer, C.E. (1) 283–295
Shen, L., see Gao, L. (1) 13–17
Shen, Z., see Luo, X. (4) 1137–1148
Shi, S., D. Liang, M. Bao, Y. Xie, W. Xu, L. Wang, Z. Wang and Z. Qiao, Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways (3) 859–871
Shin, J.S., see Kim, H.J. (3) 709–718
Shinagawa, S., see Nagata, T. (3) 839–845
Shui, G., see Chatterjee, P. (3) 887–894
Siersma, V., see Hoffmann, K. (2) 443–453
Šimić, G., see Babić Leko, M. (3) 765–778
Simonelli, I., see Siotto, M. (4) 1181–1189
Simons, K., see Maes, A. (3) 741–749
Siotto, M., I. Simonelli, P. Pasqualetti, S. Mariani, D. Caprara, S. Bucossi, M. Ventriglia, R. Molinario, M. Antenucci, M. Rongioletti, P.M. Rossini and R. Squitti, Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer’s Disease (4) 1181–1189
Sjölund, B.-M., see Wimo, A. (2) 387–396
Sköldunger, A., see Wimo, A. (2) 387–396
Slowik, A., see Dziedzic, T. (3) 623–644
Smith, A.D., see Oulhaj, A. (2) 547–557
Smith, E.E., see Fischer, C.E. (1) 283–295
Snowden, S.G., see Chatterjee, P. (3) 887–894
Snyder, P.J., see Santos, C.Y. (1) 127–131
Sobol, N.A., see Hoffmann, K. (2) 443–453
Sohrabi, H.R., see Chatterjee, P. (3) 887–894
Solas, M., see Rodriguez-Perdigon, M. (4) 963–967
Solomon, B., see Ezra, A. (1) 175–188
Song, R., see Luo, X. (4) 1137–1148
Soni, M., see Kuźma, E. (4) 1099–1108
Sorbi, S., see Oldoni, E. (2) 353–357
Spadea, F., see Malara, A. (4) 1217–1225
Spagnolo, P., see Gallucci, M. (4) 969–979
Spalletta, G., L. Cravello, W. Gianni, F. Piras, M. Iorio, C. Cacciari, A.R. Casini, C. Chiapponi, G. Sancesario, C. Fratangeli, M.D. Orfei, C. Caltagirone and F. Piras, Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment (3) 807–816
Spanò, B., see Makovac, E. (2) 591–604
Spence, J.S., see Mudar, R.A. (2) 577–590
Sperling, R.A., see Malishkevich, A. (1) 249–260
Squitti, R., see Siotto, M. (4) 1181–1189
Staekenborg, S.S., see Claus, J.J. (3) 797–806
Steenland, K., F.C. Goldstein, A. Levey and W. Wharton, A Meta-Analysis of Alzheimer’s Disease Incidence and Prevalence Comparing African-Americans and Caucasians (1) 71–76
Steubl, D., see Tholen, S. (3) 791–796
Stevens, M., see Claus, J.J. (3) 797–806
Stockburger, C., D. Miano, M. Baeumlisberger, T. Pallas, T.N. Arrey, M. Karas, K. Friedland and W.E. Müller, A Mitochondrial Role of SV2a Protein in Aging and Alzheimer’s Disease: Studies with Levetiracetam (1) 201–215
Strumia, S., see Baiardi, S. (2) 465–476
Sugawara, Y., see Sugiyama, K. (2) 491–500
Sugiyama, K., Y. Tomata, Y. Kaiho, K. Honkura, Y. Sugawara and I. Tsuji, Association between Coffee Consumption and Incident Risk of Disabling Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study (2) 491–500
Sung, H., see Lim, S. (1) 189–200
Su-Ping Lam, C., see Lim, S.L. (1) 27–40
Taddei, K., see Chatterjee, P. (3) 887–894
Takahashi, S., K. Mizukami, T. Arai, R. Ogawa, N. Kikuchi, S. Hattori, D. Darby and T. Asada, Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder (3) 751–758
Talarico, G., see Oldoni, E. (2) 353–357
Tan, L., see Wang, J. (4) 927–945
Tan, X., see Huang, F. (3) 659–667
Tantinyá, N., see Ibarria, M. (2) 559–566
Tárraga, L., see Ibarria, M. (2) 559–566
Terasawa, T., see Mishima, A. (1) 161–174
Teunissen, C.E., see Rhodius-Meester, H.F.M. (1) 261–270
Tholen, S., C. Schmaderer, S. Chmielewski, H. Förstl, U. Heemann, M. Baumann, D. Steubl and T. Grimmer, Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy? (3) 791–796
Thomas, A., see Vallortigara, J. (1) 101–110
Thouvenot, E., see Renard, D. (3) 759–764
Thyrian, J.R., see Michalowsky, B. (1) 47–59
Tielkes, C.E.M., see Claus, J.J. (3) 797–806
Tomata, Y., see Sugiyama, K. (2) 491–500
Tong, M., see Deochand, C. (2) 373–386
Tong, M., see Yu, R. (1) 133–148
Torso, M., see Makovac, E. (2) 591–604
Totsuka, M., see Hisatsune, T. (1) 149–159
Trincado, R., see Bermejo-Pareja, F. (3) 719–731
Trzepacz, P.T., see Hochstetler, H. (1) 271–282
Tseng, W.-Y.I., see Chang, Y.-L. (2) 411–423
Tsuji, I., see Sugiyama, K. (2) 491–500
Ukoumunne, O.C., see Kuźma, E. (4) 1099–1108
Ulstein, I.D., see Vijayaraghavan, S. (2) 567–576
Valero, S., see Ibarria, M. (2) 559–566
Vallortigara, J., D. Whitfield, W. Quelch, A. Alghamdi, D. Howlett, T. Hortobágyi, M. Johnson, J. Attems, J.T. O’Brien, A. Thomas, C.G. Ballard, D. Aarsland and P.T. Francis, Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia (1) 101–110
van der Flier, W.M., see Rhodius-Meester, H.F.M. (1) 261–270
van Maarschalkerweerd, W., see Claus, J.J. (3) 797–806
van Schoor, N.M., see Kuźma, E. (4) 1099–1108
Varley, R.A., see Hardy, C.J.D. (2) 359–371
Ventriglia, M., see Siotto, M. (4) 1181–1189
Vera, M., see Ibarria, M. (2) 559–566
Verdile, G., see Porter, T. (3) 895–905
Verghese, J., see Wang, N. (3) 699–707
Verschaeve, L., see Maes, A. (3) 741–749
Vestergaard, K., see Hoffmann, K. (2) 443–453
Vijayaraghavan, S., T. Darreh-Shori, A. Rongve, G. Berge, S.B. Sando, L.R. White, B.H. Auestad, A. Witoelar, O.A. Andreassen, I.D. Ulstein and D. Aarsland, Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease (2) 567–576
Vilaplana, E., see Morenas-Rodríguez, E. (2) 539–546
Vogel, A., see Hoffmann, K. (2) 443–453
von Strauss, E., see Wimo, A. (2) 387–396
Wacongne, A., see Renard, D. (3) 759–764
Waldemar, G., see Hoffmann, K. (2) 443–453
Wambacq, S., see Maes, A. (3) 741–749
Wan, Q., see Jin, H. (2) 501–516
Wang, C., see Jin, H. (2) 501–516
Wang, G., see Kennedy, R.E. (4) 1205–1215
Wang, J., L. Tan and J.-t. Yu, Prevention Trials in Alzheimer’s Disease: Current Status and Future Perspectives (4) 927–945
Wang, L., see Shi, S. (3) 859–871
Wang, N., G. Allali, C. Kesavadas, M.L. Noone, V.G. Pradeep, H.M. Blumen and J. Verghese, Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study (3) 699–707
Wang, N., see Zhang, T. (2) 455–463
Wang, S., see Hochstetler, H. (1) 271–282
Wang, S., see Zhang, Y. (4) 1163–1179
Wang, S., see Zhu, M. (4) 1149–1162
Wang, S., Y. Zhang, G. Liu, P. Phillips and T.-F. Yuan, Detection of Alzheimer’s Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging (1) 233–248
Wang, Z., see Shi, S. (3) 859–871
Warren, J.D., see Hardy, C.J.D. (2) 359–371
Warrington, E.K., see Hardy, C.J.D. (2) 359–371
Weinstein, C., see Lebowitz, B.K. (1) 41–45
Weissmann, R., M. Hüttenrauch, T. Kacprowski, Y. Bouter, L. Pradier, T.A. Bayer, A.W. Kuss and O. Wirths, Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease (2) 397–409
Wenk, M.R., see Chatterjee, P. (3) 887–894
Wermuth, L., see Hoffmann, K. (2) 443–453
Wharton, W., see Steenland, K. (1) 71–76
White, L.R., see Vijayaraghavan, S. (2) 567–576
Whitfield, D., see Vallortigara, J. (1) 101–110
Wimo, A., B.-M. Sjölund, A. Sköldunger, C. Qiu, I. Klarin, G. Nordberg and E. von Strauss, Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden (2) 387–396
Wirths, O., see Weissmann, R. (2) 397–409
Witkowski, J.M., see Bourgade, K. (4) 1227–1241
Witoelar, A., see Vijayaraghavan, S. (2) 567–576
Wolf, D., see Schuck, F. (3) 817–826
Wolf, P.A., see Lebowitz, B.K. (1) 41–45
Wruck, W., F. Schröter and J. Adjaye, Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks (4) 1065–1082
Wu, J., see Zhu, M. (4) 1149–1162
Wu, P., see Huang, F. (3) 659–667
Wu, R., see Zhu, M. (4) 1149–1162
Wu, W., see Ni, L. (4) 1243–1254
Wu, W.-C., see Santos, C.Y. (1) 127–131
Wucherer, D., see Michalowsky, B. (1) 47–59
Xie, C., see Zhu, M. (4) 1149–1162
Xie, W., see Zhu, M. (4) 1149–1162
Xie, Y., see Shi, S. (3) 859–871
Xiong, C., see Chatterjee, P. (3) 887–894
Xu, W., see Shi, S. (3) 859–871
Xu, X., see Luo, X. (4) 1137–1148
Xu, Y., see Ni, L. (4) 1243–1254
Yamashita, S., T. Kiko, H. Fujiwara, M. Hashimoto, K. Nakagawa, M. Kinoshita, K. Furukawa, H. Arai and T. Miyazawa, Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer’s Disease: Possible Interactions between Amyloid-β and These Lipids (2) 527–537
Yan, S.-H., see Chang, Y.-L. (2) 411–423
Yang, J., see Zhang, Y. (4) 1163–1179
Yang, X., see Zhu, M. (4) 1149–1162
Yasue, I., S. Matsunaga, T. Kishi, K. Fujita and N. Iwata, Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson’s Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators (3) 733–740
Yen, Y.-S., see Chang, Y.-L. (2) 411–423
Yew, B., see Nation, D.A. (3) 779–789
Yin, Z., see Ni, L. (4) 1243–1254
Yoo, S.W., see Jung, N.-Y. (4) 1125–1135
Yu, H., see Ni, L. (4) 1243–1254
Yu, J.-t., see Wang, J. (4) 927–945
Yu, P., see Hochstetler, H. (1) 271–282
Yu, R., C. Deochand, A. Krotow, R. Leão, M. Tong, A.R. Agarwal, E. Cadenas and S.M. de la Monte, Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration (1) 133–148
Yu, X., see Luo, X. (4) 1137–1148
Yuan, T.-F., see Wang, S. (1) 233–248
Yuan, T.-F., see Zhang, Y. (4) 1163–1179
Yuan-Fu Lu, S., see Melah, K.E. (3) 873–886
Zetterberg, H., see Melah, K.E. (3) 873–886
Zhang, B., see Jin, H. (2) 501–516
Zhang, B., see Ni, L. (4) 1243–1254
Zhang, F., see Qiu, H. (3) 669–685
Zhang, J., see Zhang, T. (2) 455–463
Zhang, M., see Luo, X. (4) 1137–1148
Zhang, T., H. Li, J. Zhang, X. Li, D. Qi, N. Wang and Z. Zhang, Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly (2) 455–463
Zhang, X., see Ni, L. (4) 1243–1254
Zhang, Y., S. Wang, P. Phillips, J. Yang and T.-F. Yuan, Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer’s Disease (4) 1163–1179
Zhang, Y., see Wang, S. (1) 233–248
Zhang, Z., see Zhang, T. (2) 455–463
Zhao, H., see Ni, L. (4) 1243–1254
Zhen, L., see Huang, F. (3) 659–667
Zhong, C., see Zhu, M. (4) 1149–1162
Zhong, R., see Qiu, H. (3) 669–685
Zhou, F., see Ni, L. (4) 1243–1254
Zhu, B., see Ni, L. (4) 1243–1254
Zhu, J., see Zhu, M. (4) 1149–1162
Zhu, M., C. Huang, X. Ma, R. Wu, W. Zhu, X. Li, Z. Liang, F. Deng, J. Zhu, W. Xie, X. Yang, Y. Jiang, S. Wang, J. Wu, S. Geng, C. Xie and C. Zhong, Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis (4) 1149–1162
Zhu, W., see Zhu, M. (4) 1149–1162
Zimmerer, V.C., see Hardy, C.J.D. (2) 359–371